317365-33-6

• 常用中文名：1-苄基4-(叔丁基)2-(羟甲基)哌嗪-1,4-二羧酸酯
• 常用英文名：1-BENZYL 4-TERT-BUTYL 2-(HYDROXYMETHYL)PIPERAZINE-1,4-DICARBOXYLATE
• CAS号：317365-33-6
• 分子式：C₁₈H₂₆N₂O₅
• 分子量：350.40900
• 发布时间：2017-03-28 18:47:36
• 更新时间：2026-07-01 14:49:21

名称

• 中文名: 1-苄基4-(叔丁基)2-(羟甲基)哌嗪-1,4-二羧酸酯
• 英文名: 1-Benzyl 4-tert-Butyl 2-(Hydroxymethyl)-piperazine-1,4-dicarboxylate
• 中文别名: 1-CBZ-4-BOC-2-羟甲基哌嗪; (4-BOC-1-CBZ-2-哌嗪基)甲醇
• 英文别名: 4-(tert-Butyl) 1-(benzyl) 2-(hydroxymethyl)-1,4-piperazinedicboxylate; 4-Boc-1-Cbz-2-hydroxymethylpiperazine; (R)-3-Amino-1-Cbz-pyrrolidine Hydrochloride; (R)-Benzyl 3-aMinopyrrolidine-1-carboxylate HCl; 4-tert-butyl 1-benzyl 2-(hydroxymethyl)piperazine-1,4-dicarboxylate; 1-CBZ-4-BOC-2-(hydroxymethyl)piperazine; 1-benzyl 4-tert-butyl 2-(hydroxymethyl)piperazine-1,4-dicarboxylate; 4-(1,1-Dimethylethyl) 1-(phenylmethyl) 2-(hydroxymethyl)-1,4-piperazinedicboxylate; 1-(Benzyloxycarbonyl)-4-(tert-butyloxycarbonyl)-2-hydroxymethylpiperazine; (R)-benzyl 3-aminopyrrolidine-1-carboxylate hydrochloride; (4-Boc-1-Cbz-2-piperazinyl)methanol; (R)-3-Amino-1-carbobenzoxypyrrolidine Hydrochloride; (R)-3-Amino-pyrrolidine-1-carboxylic acid benzyl ester hydrochloride; 1,4-Piperazinedicboxylic acid, 2-(hydroxymethyl)-, 4-(1,1-dimethylethyl) 1-(phenylmethyl) ester; 1-Benzyl 4-tert-Butyl 2-(Hydroxymethyl)piperazine-1,4-dicb; (R)-1-Cbz-3-AminopyrrolidineHCl; 1-BENZYL 4-TERT-BUTYL 2-(HYDROXYMETHYL)PIPERAZINE-1,4-DICBOXYLATE; (R)-3-AMino-1-N-Cbz-pyrrolidine HCl salt; 1-(benzyloxycarbonyl)-2-hydroxymethyl-4-(tert-butyloxycarbonyl)-piperazine; 1-Cbz-3R-aminopyrrolidine hydrochloride; (R)-Cbz-3-aminopyrrolidine hydrochloride; (R)-3-AMINO-1-N-CBZ-PYRROLIDINE HYDROCHLORIDE; (R)-3-AMINO-1-N-CBZ-PYRROLIDINE HCL

物化性质

• 分子式: C₁₈H₂₆N₂O₅
• 分子量: 350.40900
• 精确质量: 350.18400
• PSA: 79.31000
• LogP: 2.11260

安全

• 海关编码: 2933599090

合成路线

935544-47-1 501-53-1 ~86% 317365-33-6

文献：Clark, Roger B.; Elbaum, Daniel Tetrahedron, 2007 , vol. 63, # 14 p. 3057 - 3065

3022-15-9 501-53-1 ~53% 317365-33-6 161894-56-0

文献：CRITICAL THERAPEUTICS, INC. Patent: WO2007/146066 A2, 2007 ; Location in patent: Page/Page column 192-193 ;

301673-16-5 501-53-1 ~% 317365-33-6

文献：CRITICAL THERAPEUTICS, INC. Patent: WO2007/146066 A2, 2007 ; Location in patent: Page/Page column 83 ;

24424-99-5 ~% 317365-33-6

文献：Clark, Roger B.; Elbaum, Daniel Tetrahedron, 2007 , vol. 63, # 14 p. 3057 - 3065

143540-05-0 ~% 317365-33-6

文献：Clark, Roger B.; Elbaum, Daniel Tetrahedron, 2007 , vol. 63, # 14 p. 3057 - 3065

181955-79-3 ~% 317365-33-6

文献：Clark, Roger B.; Elbaum, Daniel Tetrahedron, 2007 , vol. 63, # 14 p. 3057 - 3065

126937-42-6 ~% 317365-33-6

文献：Hunt, Julianne A.; Beresis, Richard T.; Goulet, Joung L.; Holmes, Mark A.; Hong, Xinfang J.; Kovacs, Ernest; Mills, Sander G.; Ruzek, Rowena D.; Wong, Frederick; Hermes, Jeffrey D.; Park, Young-Whan; Salowe, Scott P.; Sonatore, Lisa M.; Wu, Lin; Woods, Andrea; Zaller, Dennis M.; Sinclair, Peter J. Bioorganic and Medicinal Chemistry Letters, 2009 , vol. 19, # 18 p. 5440 - 5443

上下游产品

上游产品  8
935544-47-1 501-53-1 3022-15-9 301673-16-5
24424-99-5 143540-05-0 181955-79-3 126937-42-6
下游产品  0

海关

海关编码	2933599090
中文概述	2933599090. 其他结构上有嘧啶环的化合物(包括其他结构上有哌嗪环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%
申报要素	品名, 成分含量, 用途, 乌洛托品请注明外观, 6－己内酰胺请注明外观, 签约日期
Summary	2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%